Trials / Unknown
UnknownNCT01112410
Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Bronchiectasis
A Randomised Double Blind 13 Week Crossover Trial of Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Patients With Bronchiectasis.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Belfast Health and Social Care Trust · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesise that nebulised hypertonic saline (6%) will increase the volume of sputum expectorated over a 24 hour period compared to nebulised isotonic saline (0.9%) in patients with mild to severe stable bronchiectasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hypertonic saline | Hypertonic saline (6%) nebulised twice a day for 4 weeks. (Randomised crossover trial) |
| OTHER | Isotonic saline | Isotonic Saline (0.9%) nebulised twice a day for 4 weeks. |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2010-04-28
- Last updated
- 2010-04-28
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01112410. Inclusion in this directory is not an endorsement.